News for Healthier Living

Time in a Bottle: How UTSW Paved the Way for a Breakthrough Brain Cancer Drug

A breakthrough medication, called vorasidenib, was approved by the Food and Drug Administration (FDA) in August 2024 to slow the growth of brain tumors. For the thousands of patients who face the ticking clock of a low-grade glioma diagnosis, the medication represents time in a bottle.

July 2, 2025


July 2 2025

July 1 2025

June 30 2025

June 29 2025

June 28 2025

June 27 2025

June 26 2025

June 25 2025

June 24 2025

June 23 2025

June 22 2025

June 21 2025

June 20 2025

June 19 2025